Literature DB >> 32413467

Contact feedback improves 1-year outcomes of remote magnetic navigation-guided ischemic ventricular tachycardia ablation.

Anna Maria Elisabeth Noten1, Astrid Armanda Hendriks1, Sing-Chien Yap2, Daniel Mol3, Rohit Bhagwandien2, Sip Wijchers2, Isabella Kardys2, Muchtiar Khan3, Tamas Szili-Torok4.   

Abstract

INTRODUCTION: Remote magnetic navigation (RMN)-guided catheter ablation (CA) is a feasible treatment option for patients presenting with ischemic ventricular tachycardia (VT). Catheter-tissue contact feedback, enhances lesion formation and may consequently improve CA outcomes. Until recently, contact feedback was unavailable for RMN-guided CA. The novel e-Contact Module (ECM) was developed to continuously monitor and ensure catheter-tissue contact during RMN-guided CA.
OBJECTIVE: The present study aims to evaluate the effect of ECM implementation on acute and long-term outcomes in RMN-guided ischemic VT ablation.
METHOD: This retrospective, two-center study included consecutive ischemic VT patients undergoing RMN-guided CA from 2010 to 2017. Baseline clinical data, procedural data, including radiation times, and acute success rates were compared between CA procedures performed with ECM (ECM+) and without ECM (ECM-). One-year VT-free survival was analyzed using Cox-proportional hazards models, adjusting for potential confounders: age, left ventricular function, VT inducibility at baseline and substrate based ablation strategy.
RESULTS: The current study included 145 patients (ECM+ N = 25, ECM- N = 120). Significantly lower fluoroscopy times were observed in the ECM+ group (9.5 (IQR 5.3-13.5) versus 12.5 min (IQR 8.0-18.0), P = 0.025). Non-inducibility of the clinical VT at the end of procedure was observed in 92% ECM+ versus 72% ECM- patients (P = 0.19). ECM guidance was associated with significantly lower VT-recurrence rates during 1-year follow-up (16% ECM+ versus 40% ECM-; multivariable HR 0.29, 95%-CI 0.10-0.69, P = 0.021, reference group: ECM-).
CONCLUSION: Contact feedback by the ECM further decreases fluoroscopy exposure and improves VT-free survival in RMN-guided ischemic VT ablation.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Catheter ablation; Contact feedback; Remote magnetic navigation; Ventricular tachycardia

Mesh:

Year:  2020        PMID: 32413467     DOI: 10.1016/j.ijcard.2020.05.028

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  The First Evaluation of Remote Magnetic Navigation-Guided Pediatric Ventricular Arrhythmia Ablation.

Authors:  Anna M E Noten; Nawin L Ramdat Misier; Janneke A E Kammeraad; Sip Wijchers; Ingrid M Van Beynum; Michiel Dalinghaus; Thomas B Krasemann; Sing-Chien Yap; Natasja M S de Groot; Tamas Szili-Torok
Journal:  Pediatr Cardiol       Date:  2022-04-29       Impact factor: 1.838

2.  Similar outcomes with manual contact force ablation catheters and traditional catheters in the treatment of outflow tract premature ventricular complexes.

Authors:  Pál Ábrahám; Mercédesz Ambrus; Szilvia Herczeg; Nándor Szegedi; Klaudia Vivien Nagy; Zoltán Salló; István Osztheimer; Gábor Széplaki; Tamás Tahin; Béla Merkely; László Gellér
Journal:  Europace       Date:  2021-04-06       Impact factor: 5.214

3.  Remote magnetic navigation shows superior long-term outcomes in pediatric atrioventricular (nodal) tachycardia ablation compared to manual radiofrequency and cryoablation.

Authors:  Anna M E Noten; Janneke A E Kammeraad; Nawin L Ramdat Misier; Sip Wijchers; Ingrid M van Beynum; Michiel Dalinghaus; Thomas B Krasemann; Sing-Chien Yap; Natasja M S de Groot; Tamas Szili-Torok
Journal:  Int J Cardiol Heart Vasc       Date:  2021-10-01

4.  Dipole charge density mapping integrated in remote magnetic navigation: First-in-human feasibility study.

Authors:  Rita B Gagyi; Anna M E Noten; Sip Wijchers; Sing-Chien Yap; Rohit E Bhagwandien; Mark G Hoogendijk; Tamas Szili-Torok
Journal:  Int J Cardiol Heart Vasc       Date:  2022-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.